tacrolimus modified release (MR)

DRUG4 trials

Sponsors

Astellas Pharma Inc

Conditions

Kidney TransplantationLiver Transplantation

Phase 2

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

CompletedNCT00282256

Astellas Pharma IncLiver Transplantation

Start: 2004-01-31End: 2008-10-31Updated: 2013-10-17

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

CompletedNCT00282243

Astellas Pharma IncLiver Transplantation

Start: 2003-02-28End: 2008-10-31Updated: 2013-09-30

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

CompletedNCT00282568

Astellas Pharma IncKidney Transplantation

Start: 2002-08-31End: 2008-10-31Updated: 2013-09-26

Phase 3

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

CompletedNCT00064701

Astellas Pharma IncKidney Transplantation

Start: 2003-06-30End: 2009-03-31Updated: 2013-12-05